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Adenoviruses (AdVs) broadly infect vertebrate hosts, including a variety of nonhuman primates 
(NHPs). In the present study, we identified AdVs in NHPs living in their natural habitats, and through 
the combination of phylogenetic analyses and information on the habitats and epidemiological 
settings, we detected possible horizontal transmission events between NHPs and humans. Wild NHPs 
were analyzed with a pan-primate AdV-specific PCR using a degenerate nested primer set that targets 
the highly conserved adenovirus DNA polymerase gene. A plethora of novel AdV sequences were 
  
identified, representing at least 45 distinct AdVs. From the AdV-positive individuals, 29 nearly 
complete hexon genes were amplified and, based on phylogenetic analysis, tentatively allocated to all 
known human AdV species (Human adenovirus A to Human adenovirus G [HAdV-A to -G]) as well as 
to the only simian AdV species (Simian adenovirus A [SAdV-A]). Interestingly, five of the AdVs 
detected in great apes grouped into the HAdV-A, HAdV-D, HAdV-F, or SAdV-A clade. Furthermore, 
we report the first detection of AdVs in New World monkeys, clustering at the base of the primate AdV 
evolutionary tree. Most notably, six chimpanzee AdVs of species HAdV-A to HAdV-F revealed a 




Primates are increasingly implicated as potential sources of emerging zoonotic diseases in humans 
(18, 59). In particular, interspecies transmission of various pathogens between humans and 
nonhuman primates (NHPs) is favored by their phylogenetic proximity (25, 35). For example, the 
worldwide pandemic of human immunodeficiency virus (HIV) resulted from various transmission 
events of the simian counterpart of the virus, simian immunodeficiency virus (SIV), from different 
primate species (19, 28). In addition, the emergence of certain acute diseases in humans, such as 
Ebola hemorrhagic fever, has been linked to contact with primates (44, 57). However, little is known 
about the potential of adenoviruses (AdVs), which are widespread in both humans and NHPs, to be 
transmitted between different primate species. 
AdVs are nonenveloped icosahedral double-stranded DNA viruses of vertebrates. They belong to the 
family Adenoviridae, which is divided into five genera (Mastadenovirus, Atadenovirus, Aviadenovirus, 
Siadenovirus, and Ichtadenovirus) (8). As of 2009, 38 AdV species have been defined by the 
International Committee on Taxonomy of Viruses (ICTV) (http://talk.ictvonline.org). These species are 
populated by more than 100 AdV types, and many AdVs have been reported that potentially represent 
additional distinct serotypes (8, 46). Most mammalian and all human AdVs (>50 serotypes) belong to 
the genus Mastadenovirus. This genus includes eight species whose members have primate hosts: 
Human adenovirus A, Human adenovirus B, Human adenovirus C, Human adenovirus D, Human 
adenovirus E, Human adenovirus F, Human adenovirus G, and Simian adenovirus A (8). 
Abbreviations (HAdV-A, etc.) are adopted below to describe the viruses that group into the cognate 
genera (Human adenovirus A, etc.). 
Typically, AdVs have a narrow host range restricted to one animal species or, as predicted by 
phylogenetic data in some cases, to closely related hosts (8, 58). Infections are predominantly 
subclinical, and overt disease develops upon the occurrence of immunosuppression or other cofactors 
(21, 32, 43, 58). Exceptions are canine AdVs, which cause epizootic respiratory disease (CAdV-1) or 
hepatitis (CAdV-2) in various carnivore species (13, 60). Certain HAdVs are associated predominantly 
with a specific pathology. Most prominent are conjunctivitis (HAdV-B and HAdV-E), keratoconjunctivitis 
(HAdV-D), acute respiratory disease (HAdV-B, HAdV-C, and HAdV-E), and (especially in children) 
gastroenteritis (HAdV-F) (47, 49). 
A number of simian adenoviruses (SAdVs) have been described. They originate from macaques 
(SAdV-1 to SAdV-15), African green monkeys (SAdV-16 to SAdV-18 and SAdV-20), baboons (SAdV-
19), and chimpanzees (SAdV-21 to SAdV-25) (1). More recently, 30 novel great ape AdVs, from 
chimpanzees, bonobos, and gorillas, as well as three macaque AdVs, were detected in captive NHPs 
held in facilities and zoological gardens in North America. Viruses were isolated from fecal samples, 
propagated in cell culture, completely sequenced, and tentatively named SAdV-25.2 to SAdV-50 (46). 
Most SAdVs were found to be very similar to HAdVs and grouped correspondingly into the HAdV-B, -
C, -E, and -G groups (see Table S1 in the supplemental material) (4, 6, 33, 34, 36, 45, 46, 56). More 
distantly related simian AdVs were assigned to SAdV-A (8, 33). AdVs infecting New World monkeys 
(NWMs) have been reported by Shroyer et al. They identified adenovirus infections in owl monkeys, 
but no sequence data are available (51). AdVs infecting Asian apes (orangutans and gibbons) have 
not been reported so far. Simian members of the HAdV-B, -C, and -E groups were found only in great 
apes, and those of the HAdV-G group were found only in Old World monkeys (OWMs). Simian 
members of the HAdV-A, -D, and -F groups are presently not known. All human and simian AdVs for 
which complete genomes are available in GenBank are listed in Table S1 in the supplemental 
material. 
Most of the SAdVs known to date were detected in or isolated from captive individuals and propagated 
in cell culture (3, 4, 6, 31, 33, 34, 36, 45, 46, 56). Unfortunately, little is known about SAdVs in wild 
  
animals. AdVs were detected in wild chimpanzees of Western Tanzania (53), and a number of AdVs 
attributable to the HAdV-B group were identified in a group of gorillas living in a remote area with little 
human presence in Loango National Park, Gabon (55). 
In the present study, we set out to investigate adenoviruses in wild primates as part of a long-term 
project on the elucidation of the etiology of primate diseases (35). Our goal was to gain insight into the 
diversity of AdVs infecting individuals living in their natural environment, to compare their AdVs with 
those published previously for captive animals, and to unravel possible horizontal transmission events 
between humans and NHPs. 
 
Materials and Methods 
Sample collection and processing.  
A total of 1,285 blood, fecal, and tissue samples were collected over a period of more than 10 years 
from live or deceased individuals of 51 primate species (great apes, OWMs, NWMs, and prosimians). 
Of these, 543 samples originated from wild primates in Africa (n = 527), Asia (n = 7), and South 
America (n = 9), 95 samples were from wild-born great apes housed in wildlife sanctuaries in West 
and East Africa, and 647 samples were derived from captive primates held in several zoological 
gardens and primate facilities in Europe and Africa. A complete list of species and samples analyzed 
is available on request. Necropsies of wild animals were performed under the highest possible safety 
standards, which included at least full body protection, a mask, face protection, and double gloves, 
and were performed in a defined area to which only protected personnel had access (35). Fecal 
samples were collected using single-use gloves and preserved in RNAlater (Qiagen, Hilden, 
Germany), in liquid nitrogen, or by drying over silica (2). DNAs from blood and tissue samples were 
prepared with a QiaAmp tissue kit (Qiagen) and DNAs from fecal samples were extracted with a 
GeneMATRIX stool DNA purification kit (Roboklon, Berlin, Germany), according to the instructions of 
the manufacturers. 
Olive baboons at Lake Manyara National Park in the United Republic of Tanzania were sampled in 
accordance with the Tanzania Wildlife Research Institute's guidelines for conducting wildlife research 
and with permission from Tanzania National Parks (TNP/HQ/E.20/08B). Additional research 
permission was granted by the Commission for Science and Technology in Tanzania (2007-56-NA-
2006-176). 
PCR methods and sequence analysis.  
(i) Generic primate AdV PCR based on the DPOL gene.  
For universal detection of AdVs, a pan-primate PCR based on the DNA polymerase (DPOL) gene was 
used as described previously (55). Briefly, two pairs of degenerate and deoxyinosine-substituted 
(deg/dI) primers were applied in a nested setup, resulting in the amplification of a 610-bp (excluding 
primer-binding sites) DPOL sequence. The generic suitability was confirmed by amplification of 
several mastadenoviruses, including human members of all HAdV species, a bat AdV (GenBank 
accession no. FJ983127), and a bovine AdV (GenBank accession no. NC006324) (data not shown). If 
the amount of amplification product was too low to permit direct sequencing, a third-round PCR 
amplifying 325 bp (excluding primer-binding sites) of the DPOL gene was performed [sense primer, 5′-
AACGCCCTCTA(y/i)GG(n/i)TC(n/i)TT; and antisense primer, 5′-
CGTCCACATCCAG(r/i)AA(n/i)GT(r/i)AT]. PCR was run as in the second round, except that the 
elongation step was 1 min at 72°C. 
(ii) Generic and LD-PCR based on the hexon gene. For amplification of partial hexon gene 
sequences, two pan-primate nested PCRs, targeting conserved regions at the 5′ and 3′ ends of the 
hexon gene, were performed as described previously, except that the elongation time was 1 min (55). 
Based on virus-specific primers (not shown) derived from the sequences of the hexon gene fragments, 
long-distance PCR (LD-PCR) was performed with the TaKaRa-EX PCR system according to the 
instructions of the manufacturer (Takara Bio Inc., Otsu, Japan).  
(iii) PCR for amplification of PtroAdV-3. To amplify 454 bp of the DPOL gene of Pan troglodytes 
adenovirus 3 (PtroAdV-3), a nested PCR was performed using the sense primer 5′-
GCTGGCATGTGCGGTTGCTT and the antisense primer 5′-TCCACCAGGGGGTCGACCTTT in the 
1st round and the sense primer 5′-GGCGCTGCGTGGCAAAAGAG and the antisense primer 5′-
AGGGTGTGAAGGCAAAGGTCATCT in the 2nd round. Conditions were as described for the second 
round of the generic DPOL PCR, except that the annealing temperature was 60°C and the elongation 
step was 1 min at 72°C. 
  
(iv) Generic real-time PCR targeting AdVs related to HAdV-F and HAdV-G. For selective 
amplification of unknown AdVs related to HAdV-F and -G, primers (sense primer, 
GCATACTCACCCGAACAGC; and antisense primer, GGTCATCTTCCTCYGCRTCCA) and a TaqMan 
probe (FAM-CCACAGCGATGCGGAAGAAAGTGA-BBQ [FAM, 6-carboxyfluorescein]) were selected 
which bind to sites conserved in the DPOL genes of HAdV-F and HAdV-G members only. The PCR 
was performed in a total volume of 25 μl with 0.2 μl Platinum Taq polymerase (Applied Biosystems, 
Darmstadt, Germany), 10 μM (each) primers, 10 nM probe, a 200 μM concentration of each 
deoxynucleoside triphosphate (dNTP), and 50 mM MgCl2. An MX 3000P thermal cycler (Stratagene, 
Waldbronn, Germany) was used with the following cycling conditions: 95°C for 5 min and 45 cycles of 
95°C for 30 s and 60°C for 30 s. Analysis was performed with MXPro V 4.0 software from Stratagene. 
(v) Sequencing. All PCR products were purified by using a PCR purification kit (Qiagen) and were 
sequenced directly with a BigDye Terminator cycle sequencing kit (Applied Biosystems, Warrington, 
Great Britain) in a model 377 automated DNA sequencer (Applied Biosystems). 
PCR system according to the instructions of the manufacturer (Takara Bio Inc., Otsu, Japan). 
Phylogenetic analysis of DPOL sequences.Amino acid sequence alignments of DPOL gene 
sequences were generated using the MAFFT multiple-aligner plug-in of Geneious Pro 5.1.4 software 
(Biomatters Ltd., Auckland, New Zealand) (27). Regions that were considered too variable to be 
aligned with confidence, in addition to sites containing a gapping character in any sequence, were 
eliminated before using the alignment for phylogenetic inference. Phylogenetic trees were inferred 
from alignments of amino acid sequences (all alignments are available on request). Phylogenetic 
relationships were investigated with trees built by the maximum likelihood (ML) method, using the 
PhyML 2.0.1 plug-in (22). The nucleotide substitution model to which the data best fit was estimated 
by jModeltest v0.1.1 (23, 42), and the HKY85+I+G model was applied. Reliability of the trees was 
analyzed by bootstrap analysis (100-fold resampling). 
Phylogenetic analysis of hexon sequences.Sequences were added to a data set consisting of all 
hexon gene sequences available from completely sequenced AdV genomes (see Table S1 in the 
supplemental material). The AdVs CAdV-1 and bovine adenovirus type 3 (BAdV-3) served as 
outgroups. Hexon protein sequences were first aligned in SeaView v4 by using the program Muscle 
(15, 16, 20). To identify and remove blocks of the alignment where the hypothesis of homology was 
likely to be overoptimistic, the Gblocks server 
(http://molevol.cmima.csic.es/castresana/Gblocks_server.html) was employed, a strategy confirmed to 
lead to better inference of phylogenetic trees (52). Corresponding blocks from the nucleotide 
alignment were eliminated, and the overall process resulted in a data set composed of 114 sequences 
of 1,403 nucleotides. The nucleotide substitution model to which the data were best fit was determined 
using jModeltest v0.1.1 (22, 42). Substitution schemes were examined along with rate variation (+I, 
+G, and +I+G) and base frequency (+F) modeling. Base trees for calculations were optimized by the 
ML method (23). According to the Akaike information criterion (AIC), comparisons of model likelihoods 
indicated that the global timer reversible GTR+I+G model was more favorable. Phylogenetic analyses 
were performed in both ML and Bayesian frameworks. ML analysis was performed with Sea View v4 
(20), using the PhyML option under predefined conditions. Equilibrium frequencies, topology, and 
branch lengths were optimized, the starting tree was determined using BioNJ, and both nearest-
neighbor interchange (NNI) and subtree pruning and regrafting (SPR) algorithms for tree searching 
were used. Branch robustness was analyzed by bootstrap analysis (100-fold resampling). 
Bayesian analyses were performed using BEAST v1.6.1 (14). Calculations were run under the 
assumption of a relaxed, uncorrelated log-normal clock and using the Yule process speciation model. 
A run of 4,000,000 generations was performed. Trees and numerical values taken for all parameters 
were sampled every 1,000 generations. Tracer v1.5 was used to verify that the run converged on the 
same zones of parameter spaces and that chain mixing was satisfactory (global effective sample size 
value of >100) (14). Tree information was summarized on the maximum clade credibility tree by using 
TreeAnnotator v1.6.1 (distributed with BEAST). Posterior probabilities were taken as a measure of 
branch robustness. 
Nucleotide sequence accession numbers.For the purposes of this paper, preliminary names and 
abbreviations for the candidate novel AdVs were derived from the species name of the host in which 
the virus was detected (for example, the abbreviation of Pan troglodytes adenovirus is PtroAdV). The 
GenBank accession numbers for their hexon sequences are as follows: Pan troglodytes schweinfurthii 
adenovirus 1, JN163971; Pan troglodytes schweinfurthii adenovirus 2, JN163972; Pan troglodytes 
verus adenovirus 3, JN163973; Pan troglodytes verus adenovirus 4, JN163974; Pan troglodytes verus 
adenovirus 5, JN163975; Pan troglodytes schweinfurthii adenovirus 6, JN163976; Pan troglodytes 
schweinfurthii adenovirus 7, JN163977; Pan troglodytes verus adenovirus 8, JN163978; Pan 
  
troglodytes schweinfurthii adenovirus 9, JN163979; Pan troglodytes schweinfurthii adenovirus 10, 
JN163980; Pan troglodytes schweinfurthii adenovirus 11, JN163981; Pan troglodytes schweinfurthii 
adenovirus 12, JN163982; Pan troglodytes schweinfurthii adenovirus 13, JN163983; Pan troglodytes 
schweinfurthii adenovirus 14, JN163984; Gorilla gorilla gorilla adenovirus 1, JN163985; Gorilla gorilla 
gorilla adenovirus 2, JN163986; Gorilla gorilla beringei adenovirus 3, JN163987; Gorilla gorilla beringei 
adenovirus 4, JN163988; Gorilla gorilla beringei adenovirus 5, JN163989; Gorilla gorilla beringei 
adenovirus 6, JN163990; Papio hamadryas adenovirus 1, JN163991; Macaca fascicularis adenovirus 
1, JN163992; Macaca mulatta adenovirus 1, JN163993; Colobus guereza adenovirus 1, JN163994; 
Colobus guereza adenovirus 2, JN163995; Colobus guereza adenovirus 3, JN163996; Piliocolobus 
badius adenovirus 1, JN163997; Piliocolobus badius adenovirus 2, JN163998; and Piliocolobus 
badius adenovirus 3, JN163999. 
 
Results and Discussion 
De novo detection of novel AdVs.The aims of this study were to comprehensively investigate the 
diversity of AdVs in wild NHPs, to compare their AdVs with those published previously for captive 
animals, and to unravel possible horizontal transmission events between humans and NHPs. For 
these purposes, blood, tissue, and fecal samples (n = 1,285) which had been collected from live or 
deceased individuals of 52 primate species (great apes, OWMs, NWMs, and prosimians) were 
analyzed with a generic DPOL PCR. From 218/1,285 samples (17%), PCR products of the expected 
size were obtained, sequenced, and proven by BLAST analysis to originate from as yet unknown 
AdVs. Fecal samples were the predominant source of AdV sequences, since 59% were PCR positive. 
Far fewer AdV sequences were detected in organ specimens: of all organ types with >40 samples 
tested, the intestine, spleen, lymph nodes, and liver were the best sources of AdV sequences (27%, 
7%, 5%, and 6% of samples, respectively). In contrast, AdVs were detected only once in kidney, lung, 
and blood samples (2%, 1%, and 0.3% of samples, respectively) (Table 1). In total, the sequences 
indicated the presence of 45 potentially novel AdVs. For six AdVs, only the third PCR round yielded 
enough product for direct sequence analysis (325 bp). The AdV-positive primate hosts originated from 
eight countries in Africa, namely, Cameroon, Democratic Republic of Congo, Gambia, Côte d'Ivoire, 
Republic of Congo, Rwanda, Tanzania, and Uganda, as well as from a primate facility and several 
zoos in Germany (see Table 3). Primate hosts were members of eight different genera, six of the 
Catarrhini (Colobus, Gorilla, Macaca, Pan, Papio, and Piliocolobus) and two of the Platyrrhini 
(Callithrix and Saguinus). Prosimian AdVs were not detected. The AdV sequences identified in wild 
primates originated from chimpanzees, bonobos, gorillas, baboons, and two colobus species. Captive 
primate species revealing AdV sequences were mantled guerezas, rhesus macaques, cynomolgus 
macaques, marmosets, and tamarins. Taken together, 11/52 primate species yielded AdV sequences, 
with the moderate detection rate (17%) most likely being due to limitations in sample materials (e.g., 
the lack of fecal and intestinal samples). The primate species that yielded AdV sequence data and the 
tentative assignments of AdVs to HAdV species are listed in Table 2, and the countries of origin, 
sample types, and numbers of PCR-positive individuals are given in Table 3. The authenticity of the 
PCR-positive host individuals was controlled by amplification of cytB sequences from the specimens 
by PCR (data not shown), as performed previously (17). 
BLAST analysis and preliminary phylogenetic tree construction using ML calculations revealed a high 
level of genetic diversity of the novel AdVs. They exhibited a broad evolutionary spectrum and were 
tentatively allocated to all HAdV species known (Human adenovirus A to Human adenovirus G) 
(Tables 1 and 3; Fig. 1). AdVs of great apes clustered predominantly in the HAdV-B, HAdV-C, and 
HAdV-E groups, i.e., most AdVs detected in gorillas clustered in HAdV-B (53/58 individuals), with 
AdVs from chimpanzees clustering mainly within HAdV-C (21/107 individuals) and HAdV-E (72/107 
individuals). AdVs discovered in OWMs clustered in HAdV-G or could not be assigned to an AdV 
species, since they branched in the deeper part of the DPOL tree, in the vicinity of HAdV-G and SAdV-
A, with weak statistical support (Fig. 1). Earlier reports already indicated that AdVs of captive NHPs 
can be allocated to all HAdV species (except for Human adenovirus A and Human adenovirus D) (8, 
34, 46). However, a concern was raised about the true origin of AdVs from captive primates because 
humans and NHPs are frequently in close contact in zoos and primate facilities (46). With this in mind, 
our findings for wild primates are of significance because they confirm that AdVs of groups HAdV-B, -
C, -E, -F, and -G populate NHPs. In addition, two observations were novel: (i) AdVs that grouped into 
HAdV-A, HAdV-D, HAdV-F, and SAdV-A were detected in great apes; and (ii) AdVs were identified in 
NWMs that clustered in a well-separated clade at the base of the primate AdV tree, possibly reflecting 
the split between NWMs and OWMs (Tables 2 and 3; Fig. 1). The high level of conservation of the 
adenovirus DPOL gene ensured the broad detection of AdVs, but the limited length of the amplified 
fragment (610 bp) impeded the proper differentiation of AdVs allocated to the same species. 
  
Therefore, our inferences on the phylogeny of the novel AdVs required backup data for a more 
suitable gene. The hexon gene was chosen, since serotype specificity of AdV capsids correlates well 
with variations in hexon sequences (48). Furthermore, it is part of the species demarcation criteria 
applied by the ICTV (8). To determine nearly complete hexon gene sequences, we initially amplified 
short regions at the 5′ and 3′ ends of the hexon gene by use of degenerate primers. The products 
were then connected by LD-PCR, resulting in a contiguous hexon sequence of approximately 2.5 kb. 
This was successful for 29 of the 45 AdVs. For the remaining 16 AdVs, either one or both of the two 
generic hexon PCRs failed (data not shown). For most novel AdVs, both DPOL and hexon sequences 
were available from the same sample but could not be connected by LD-PCR amplification of the 
interspersed sequence. This was probably due to copy numbers being too low for amplification of >10 
kb, to poor sample quality, or to the presence of more than one AdV. Therefore, it was not possible to 
unequivocally prove that both sequences derived from the same virus. In addition, five chimpanzee 
AdVs allocated to HAdV-E (PtroAdV-1, PtroAdV-11, PtroAdV-12, PtroAdV-13, and PtroAdV-14) 
revealed distinct hexon sequences (pairwise hexon nucleic acid identities of 86.1 to 93.8%) but 
indistinguishable DPOL sequences in the respective samples. This indicated that identical DPOL 
sequences do not always originate from identical AdV genomes. We concluded that the 45 distinct 
AdV DPOL sequences detected in this study represent a subset of the AdVs present in the samples 
analyzed and that the allocation to certain AdV species, as well as provisional naming of the novel 
AdVs, had to be based on the hexon gene sequences. Since the occurrence of interspecies 
recombination involving the hexon gene had been suspected (11, 37,–,39, 54), this species allocation 
was tentative. 
A hexon-based phylogenetic analysis was carried out using an ML calculation. The resulting tree (Fig. 
2) was in overall accordance with the DPOL-derived tree (Fig. 1), and its general topology was the 
same as that revealed in previous reports (12, 46). In contrast to the DPOL tree, in which several 
deeper nodes were statistically poorly supported, thus inhibiting the determination of the relationships 
between the AdV clades, the hexon-based tree yielded high bootstrap support all over the tree (Fig. 
2). In addition, a tree constructed by Bayesian analysis revealed the same tree topology (data not 
shown). Since one of our goals was to comprehensively describe the diversity in AdVs in free-ranging 
individuals and to compare these viruses with AdVs infecting captive animals, several findings deserve 
attention. In light of current knowledge, AdVs of wild great apes would be expected to populate only 
the HAdV-B, -C, and -E clades, since AdVs were detected previously in captive individuals and 
allocated to HAdV-B, -C, and-E (45, 46). In addition, HAdV-B viruses were detected recently in wild 
Western lowland gorillas (G. g. gorilla) (55). However, in this study, we also detected AdVs in wild 
great apes that were attributable to groups HAdV-A, HAdV-D, HAdV-F, and SAdV-A. Three of these 
(PtroAdV-8 [HAdV-A], PtroAdV-10 [HAdV-D], and PtroAdV-3 [HAdV-F]), as well as two additional 
viruses (PtroAdV-7 [HAdV-B] and PtroAdV-14 [HAdV-E]), revealed a remarkably close relationship to 
human AdVs over the entire hexon gene sequence (Fig. 2). 
Current knowledge about AdVs in wild NHPs is scarce (53, 55), and most studies on NHP AdVs 
involve captive animals from zoos and animal facilities (3, 4, 6, 10, 24, 30, 31, 33, 34, 36, 40, 45, 46, 
56, 61). Therefore, our study on wild primates is of importance because it provides insight into natural 
AdV diversity and evolution. A general outcome of our phylogenetic data set is that all seven HAdV 
species contain both human- and simian-derived AdVs (Fig. 1). However, we confirmed that two HAdV 
species contain AdVs from predominantly one host species or one host family only: AdVs classified 
into the HAdV-D species are found almost exclusively in humans, and AdVs of the HAdV-E species 
appear to originate almost entirely from chimpanzees (Fig. 1). The exceptions are as follows. 
(i) HAdV-D. The chimpanzee AdV clustering in HAdV-D (PtroAdV-10) showed 99% pairwise hexon 
nucleic acid identity to HAdV-15 and 98% identity to HAdV-29 and -30. As expected, the PtroAdV-10 
position was closest to HAdV-15 in the hexon-based phylogenetic tree (Fig. 2). This finding added a 
new quality to HAdV-D, i.e., a great ape AdV was added to a hitherto strictly human AdV cluster of 32 
serotypes. Among human AdVs, HAdV-D is the largest and fastest growing species. Based on the 
variability of the genome regions responsible for serotype specificity, the ultimate number of serotypes 
may be very large (11). In contrast, PtroAdV-10 was found in only one individual, from the Budongo 
Forest area in Uganda. Although we did not search for PtroAdV-10 in chimpanzees by using a specific 
PCR, the lack of HAdV-D sequences in other primate individuals revealed by the generic DPOL PCR 
led us to hypothesize that PtroAdV-10 is of human origin, i.e., it is a putative variant of HAdV-15 
circulating in the human population in Central Africa. 
(ii) HAdV-E. One human AdV (HAdV-4), 11 chimpanzee AdVs, and 1 bonobo AdV (46) are presently 
allocated to HAdV-E. In the present study, the majority (79%) of the fecal samples from 94 
chimpanzees and 7 bonobos that were positive in the generic DPOL PCR belonged to HAdV-E, and 
from the chimpanzee samples, six distinct hexon sequences could be amplified and tentatively named 
  
(PtroAdV-1, -5, -11, -12, -13, and -14). Notably, PtroAdV-14, identified in a wild animal in Uganda, was 
determined to be the closest known counterpart of HAdV-4, since it revealed a pairwise hexon nucleic 
acid identity of 93.6% and clustered most closely with HAdV-4 in the hexon-based tree (Fig. 2). This 
reinforces the previous hypothesis (43) that HAdV-4 is the result of a zoonotic transmission event from 
chimpanzees to humans. 
(iii) HAdV-B and HAdV-C. The occurrence of a predominant host species, as in HAdV-D and HAdV-
E, does not seem to be a hallmark for AdVs of HAdV-B and HAdV-C. Rather, these groups are 
populated with human AdVs and with those of different NHPs. HAdV-B encompasses AdVs of human, 
chimpanzee, gorilla, and bonobo origin. We discovered AdVs belonging to HAdV-B in 53 gorillas and 6 
chimpanzees, thus confirming for wild individuals that members of HAdV-B widely infect great apes. 
However, viruses of the same host species stray throughout the clade, and several subclades 
comprising AdVs of different hosts are visible (Fig. 2). This was observed even for viruses (GgorAdV-3 
to GgorAdV-5) that were identified in a geographically isolated population of mountain gorillas (G. g. 
beringei) (Fig. 2; Table 2). PtroAdV-7 deserves special attention, since it is the first AdV in a wild 
chimpanzee population with remarkable similarity to a human AdV of HAdV-B (pairwise hexon nucleic 
acid identity to HAdV-50, 99.2%). Taken together, the evidence shows that interspecies transmissions 
are a general driving force in the evolutionary history of human and NHP adenoviruses of the HAdV-B 
species. The completely mixed architecture of the HAdV-B clade does not allow speculations about 
the directionality of transmissions, although several viruses were detected in chimpanzee and gorilla 
individuals from remote areas without contact with humans. This may indicate that human HAdV-B 
originated in great apes, but further studies are clearly required to settle this issue. HAdV-C also 
encompasses AdVs of human, chimpanzee, gorilla, and bonobo origin. Of 101 fecal samples from 
chimpanzees, 21 tested positive for AdVs of the HAdV-C species. Also, AdVs of the HAdV-C species 
were detected in four fecal samples from wild gorillas. Interestingly, the viruses of each host species 
clustered in distinct subclades. This most likely reflects their origin by coevolutionary processes, with 
no evidence of horizontal transmission events (Fig. 2). 
(iv) HAdV-A, HAdV-F, HAdV-G, and SAdV-A. Four primate AdV species (HAdV-A, HAdV-F, HAdV-
G, and SAdV-A) presently comprise 10 AdVs or fewer (including our data) and are discussed 
separately below. 
HAdV-A is presently populated with three human AdVs only. From a chimpanzee from Côte d'Ivoire, a 
hexon sequence was amplified and tentatively named PtroAdV-8. In the phylogenetic analysis, it was 
closely related to HAdV-12 (Fig. 2) (pairwise hexon nucleic acid identity of 95.7%), implying that 
PtroAdV-8 or its ancestor may have originated from a transmission event between humans and 
chimpanzees. However, we detected nearly identical HAdV-A DPOL sequences in chimpanzees from 
different subspecies and located at large geographic distances, i.e., two P. t. verus chimpanzees from 
Côte d'Ivoire and one P. t. schweinfurthii chimpanzee from Uganda, indicating that HAdV-A members 
are established in chimpanzees. More data from human and chimpanzee populations are needed to 
substantiate this hypothesis (Fig. 1 and 2). 
HAdV-F is comprised of two human AdVs (HAdV-40 and -41), and an OWM-AdV (SAdV-18) may also 
belong to HAdV-F (Fig. 2). We discovered one chimpanzee and one gorilla AdV (PtroAdV-3 and 
GgorAdV-1) attributable to HAdV-F (Fig. 2). In addition, five novel OWM-AdVs were detected to cluster 
more closely with HAdV-F than with other HAdVs (Fig. 2 and Table 4; see Table S1 in the 
supplemental material). PtroAdV-3 was detected in necropsy samples from a wild chimpanzee from 
the River Gambia National Park, Gambia. The lungs, liver, and spleen were PCR positive (the 
intestine and feces were not available). PtroAdV-3 revealed a pairwise hexon nucleic acid identity of 
99.8% to HAdV-40 (Fig. 1). Despite attempts to identify PtroAdV-3 in other chimpanzees by use of a 
specific PCR (data not shown), the virus was detected only in the index individual. Since the 
chimpanzee from Gambia had been fed by humans over a long period, it is possible that the virus was 
transmitted from humans to this chimpanzee. Nothing is known about possible contacts of the gorilla 
from Gabon hosting GgorAdV-1. 
For HAdV-G, four novel monkey AdVs were detected to have a close relationship to HAdV-52 (Fig. 1 
and 2). This HAdV type was discovered recently in the United States in samples from human patients 
with gastroenteritis of unknown etiology, and its close relatedness to some SAdVs was discussed as 
evidence of a recent common ancestor (26). However, concern was raised that HAdV-52 was in fact a 
simian AdV contaminating the primary monkey cell culture used for the isolation of this virus, and 
evidence of its circulation in other parts of the world is lacking (5). The four novel monkey AdVs 
(MfasAdV-1, MmulAdV-1, PhamAdV-1, and CgueAdV-2) detected in this study and those identified 
very recently in captive rhesus monkeys in China (36), all branching closely around HAdV-52, 
  
underscore the above hypothesis that HAdV-52 may be a simian AdV originating from cultivated 
monkey cells. 
The novel AdV species SAdV-A presently comprises only one AdV (of rhesus macaques), and two 
additional monkey AdVs (of cynomolgus and rhesus macaques) have been allocated tentatively (8, 
46). We discovered a chimpanzee AdV (PtroAdV-2) as potentially belonging to SAdV-A, as revealed 
by hexon-based phylogenetic analysis (Fig. 2). PtroAdV-2 was discovered in a chimpanzee of the 
Budongo Forest area, Uganda. Since PtroAdV-2 has no closely related monkey counterpart, it remains 
unclear if it is a genuine great ape AdV or an AdV of monkey origin. Nevertheless, it adds a new 
qualifier to the species SAdV-A, and it is of great interest whether additional members of SAdV-A are 
circulating in great ape or human populations. 
AdVs of clades HAdV-A, -B, -D, and -F and SAdV-A were identified only rarely in wild chimpanzees, 
and HAdV-G was not detected at all (Table 1; Fig. 1). Instead, 87% of the AdVs detected were HAdV-
E and -C members, possibly inhibiting the detection of other AdV types by generic PCR. Therefore, we 
set up a real-time PCR with nondegenerate primers for the selective amplification of HAdV-F and -G 
members in order to exclude the possible detection of any other HAdV species. Fecal samples of 
chimpanzees (n = 113) were tested, but sequences attributable to HAdV-F or -G were not detected 
(data not shown). We concluded from these findings that HAdV-F and -G do not genuinely occur in 
chimpanzees, and since HAdV-F viruses are endemic in most countries (29, 50), the single 
chimpanzee HAdV-F virus (PtroAdV-3) with 99.8% identity to HAdV-40 is most likely the result of a 
very recent human-to-chimpanzee interspecies transmission event. In addition, the obvious lack of 
HAdV-G in chimpanzees further supports the above notion that HAdV-52 may have originated from an 
OWM. 
Although extensive molecular evidence has accumulated in the literature to indicate that AdVs 
coevolved with their respective hosts, showing remarkable restrictions in their host range (7, 12), 
previous reports also corroborate the possibility of interspecies transmission of primate AdVs (26, 43). 
The most striking evidence of the zoonotic potential of primate AdVs emerged from the very recent 
respiratory illness of a scientist who appeared to have been infected with an unknown AdV while 
investigating a fatal outbreak of pneumonia and hepatitis in a colony of Titi monkeys (NWMs) at the 
California National Primate Research Centre in Davis, CA (10). In the present study, several lines of 
genetic evidence of recent interspecies transmissions of AdVs were obtained. Taken together, these 
data underscore the concept of AdVs having the potential to cross the borders between closely related 
host species, in particular those between NHPs and humans. 
It is estimated that 75% of the infectious diseases affecting humans are of zoonotic origin, with severe 
consequences for public health (41). Since primates, particularly great apes, and humans are very 
similar in their physiological and genetic properties, studying the primate “virome” may provide 
information on viral candidates with the potential to infect humans (18). Transmission of such viruses 
is most likely to occur at places with close physical contact between NHPs and humans, such as zoos 
and other animal facilities (10). Sub-Saharan Africa deserves special attention, since hunting and 
preparation of primate meat create high exposure rates. In addition, the susceptibility to viral infections 
may be enhanced due to high HIV infection rates in local populations (9). Given the need to protect 
both public health and endangered NHPs and the fact that a number of AdVs have been linked firmly 
to human diseases, the large variety of known and novel AdVs in great apes and monkeys calls for 
larger studies to understand the diversity of AdVs currently circulating in African primates as well as in 
local human populations (18, 35). This may answer the intriguing question of whether NHPs and 
humans have an intersected “adeno-virosphere” and may provide the basis for elucidating the 
potential pathological consequences of interspecies AdV transmissions. 
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Table S1     Adenoviruses, abbreviations, and accession numbers 
Adenovirus  Abbreviation Acc.-no. a  Host 
Human adenovirus A b     
Human adenovirus 12 HAdV-12 NC 001460 Human 
Human adenovirus 18 HAdV-18 GU191019  
Human adenovirus 31 HAdV-31 AM749299  
Pan troglodytes adenovirus 8 c PtroAdV-8 JN163978 Chimpanzee 
    
Human adenovirus B    
Human adenovirus 3 HAdV-3 DQ086466 Human 
Human adenovirus 7 HAdV-7 AC 000018  
Human adenovirus 11 HAdV-11 AY163756  
Human adenovirus 14 HAdV-14 AY803294  
Human adenovirus 16 HAdV-16 AY601636  
Human adenovirus 21 HAdV-21 AY601633  
Human adenovirus 34 HAdV-34 AY737797  
Human adenovirus 35 HAdV-35 AY271307  
Human adenovirus 50 HAdV-50 AY737798  
Simian adenovirus 21 SAdV-21 AC 000010 Chimpanzee 
Simian adenovirus 27.1 SAdV-27.1 FJ025909  
Simian adenovirus 27.2 SAdV-27.2 FJ025928 Gorilla 
Simian adenovirus 28.1 SAdV-28.1 FJ025914 Chimpanzee 
Simian adenovirus 28.2 SAdV-28.2 FJ025915 Gorilla 
Simian adenovirus 29 SAdV-29 FJ025916 Chimpanzee 
Simian adenovirus 32 SAdV-32 FJ025911  
Simian adenovirus 33 SAdV-33 FJ025908  
Simian adenovirus 35.1 SAdV-35.1 FJ025912  
Simian adenovirus 35.2 SAdV-35.2 FJ025910 Bonobo 
Simian adenovirus 41.1 SAdV-41.1 FJ025913 Gorilla 
Simian adenovirus 41.2 SAdV-41.2 FJ025927  
Simian adenovirus 46 SAdV-46 FJ025930  
Simian adenovirus 47 SAdV-47 FJ025929  
Gorilla gorilla adenovirus B7 GgorAdV-B7 HQ292614  
Gorilla gorilla adenovirus 2 GgorAdV-2 JN163986 Gorilla 
Gorilla gorilla adenovirus 3 GgorAdV-3 JN163987  
Gorilla gorilla adenovirus 4 GgorAdV-4 JN163988  
Gorilla gorilla adenovirus 5 GgorAdV-5 JN163989  
Pan troglodytes adenovirus 7 PtroAdV-7 JN163977 Chimpanzee 
    
Human adenovirus C    
Human adenovirus 1 HAdV-1 AF534906 Human 
Human adenovirus 2 HAdV-2 NC 001405  
Human adenovirus 5 HAdV-5 AC 000008  
Human adenovirus 6 HAdV-6 FJ349096  
Simian adenovirus 31.1 SAdV-31.1 FJ025906 Chimpanzee 
Simian adenovirus 31.2 SAdV-31.2 FJ025904  
Simian adenovirus 34 SAdV-34 FJ025905  
Simian adenovirus 40.1 SAdV-40.1 FJ025907  
Simian adenovirus 40.2 SAdV-40.2 FJ025926  
Simian adenovirus 42.1 SAdV-42.1 FJ025903 Bonobo 
Simian adenovirus 42.2 SAdV-42.2 FJ025902  
Simian adenovirus 42.3 SAdV-42.3 FJ025925  
Simian adenovirus 43 SAdV-43 FJ025900 Gorilla 
Simian adenovirus 44 SAdV-44 FJ025899 Bonobo 
Simian adenovirus 45 SAdV-45 FJ025901 Gorilla 
a GenBank and RefSeq accession numbers  
b The allocation of the novel AdVs to an adenovirus species is tentative  
c All novel viruses in bold type 
  
 
…….Table S1 continued 
Adenovirus Abbreviation Acc.-no. a  Host 
Human adenovirus C b    
Gorilla gorilla adenovirus 6 c GgorAdV-6 JN163990 Gorilla 
Pan troglodytes adenovirus 4 PtroAdV-4 JN163974 Chimpanzee 
Pan troglodytes adenovirus 6 PtroAdV-6 JN163976  
Pan troglodytes adenovirus 9 PtroAdV-9 JN163979  
    
Human adenovirus D    
Human adenovirus 8 HAdV-8 AB448767 Human 
Human adenovirus 9 HAdV-9 AJ854486  
Human adenovirus 17 HAdV-17 AF108105  
Human adenovirus 19 HAdV-19 AB448774  
Human adenovirus 22 HAdV-22 FJ619037  
Human adenovirus 26 HAdV-26 EF153474  
Human adenovirus 28 HAdV-28 FJ824826  
Human adenovirus 29 HAdV-29 AB562587  
Human adenovirus 30 HAdV-30 DQ149628  
Human adenovirus 36 HAdV-36 GQ384080  
Human adenovirus 37 HAdV-37 AB448778  
Human adenovirus 46 HAdV-46 AY875648  
Human adenovirus 48 HAdV-48 EF153473  
Human adenovirus 49 HAdV-49 DQ393829  
Human adenovirus 53 HAdV-53 FJ169625  
Human adenovirus 54 HAdV-54 AB333801  
Pan troglodytes adenovirus 10 PtroAdV10 JN163980 Chimpanzee 
    
Human adenovirus E    
Human adenovirus 4 HAdV-4 AY458656 Human 
Simian adenovirus 22 SAdV-22 AY530876 Chimpanzee 
Simian adenovirus 23 SAdV-23 AY530877  
Simian adenovirus 24 SAdV-24 AY530878  
Simian adenovirus 25.1 SAdV-25.1 AC 000011  
Simian adenovirus 25.2 SAdV-25.2 FJ025918  
Simian adenovirus 26 SAdV-26 FJ025923  
Simian adenovirus 30 SAdV-30 FJ025920  
Simian adenovirus 36 SAdV-36 FJ025917  
Simian adenovirus 37.1 SAdV-37.1 FJ025921  
Simian adenovirus 37.2 SAdV-37.2 FJ025919 Bonobo 
Simian adenovirus 38 SAdV-38 FJ025922 Chimpanzee 
Simian adenovirus 39 SAdV-39 FJ025924  
Pan troglodytes adenovirus 1 PtroAdV-1 JN163971 Chimpanzee 
Pan troglodytes adenovirus 5 PtroAdV-5 JN163975  
Pan troglodytes adenovirus 11 PtroAdV-11 JN163981  
Pan troglodytes adenovirus 12 PtroAdV-12 JN163982  
Pan troglodytes adenovirus 13 PtroAdV-13 JN163983  
Pan troglodytes adenovirus 14 PtroAdV-14 JN163984  
a GenBank and RefSeq accession numbers  
b The allocation of the novel AdVs to an adenovirus species is tentative  
c All novel viruses in bold type 
  
…….Table S1 continued 
Adenovirus Abbreviation Acc.-no. a  Host 
Human adenovirus F b    
Human adenovirus 40 HAdV-40 NC 001454 Human 
Human adenovirus 41 HAdV-41 DQ315364  
Gorilla gorilla adenovirus 1 c  GgorAdV-1 JN163985 Gorilla 
Pan troglodytes adenovirus 3 PtroAdV-3 JN163973 Chimpanzee 
    
Human adenovirus G    
Human adenovirus 52 HAdV-52 DQ923122 Human 
Simian adenovirus 1 SAdV-1 AY771780 Cynomolgus macaque 
Simian adenovirus 7 SAdV-7 DQ792570 Rhesus macaque 
Macaca mulatta adenovirus 1 MmulAdV-1 JN163993 Rhesus macaque 
Macaca fascicularis adenovirus 1 MfasAdV-1 JN163992 Cynomolgus macaque 
    
Simian adenovirus A    
Simian adenovirus 3 SAdV-3 AY598782 Rhesus macaque 
Simian adenovirus 6 SAdV-6 CQ982401  
Simian adenovirus 48 SAdV-48 HQ241818 Cynomolgus macaque 
Pan troglodytes adenovirus 2 PtroAdV-2 JN163972 Chimpanzee 
    
Unassigned adenoviruses    
Simian adenovirus 18 SAdV-18 FJ025931 African green monkey 
Simian adenovirus 49 SAdV-49 HQ241819 Cynomolgus macaque 
Simian adenovirus 50 SAdV-50 HQ241820  
Colobus guereza adenovirus 1 CgueAdV-1 JN163994 Mantled guereza 
Colobus guereza adenovirus 2 CgueAdV-2 JN163995  
Colobus guereza adenovirus 3 CgueAdV-3 JN163996  
Papio hamadryas adenovirus 1 PhamAdV-1 JN163991 Hamadryas baboon 
Piliocolobus badius adenovirus 1 PbadAdV-1 JN163997 Western red colobus 
Piliocolobus badius adenovirus 2 PbadAdV-2 JN163998  
Piliocolobus badius adenovirus 3 PbadAdV-3 JN163999  
    
Non-primate AdV    
Bovine adenovirus 3 BAdV-3 AC 000002 Cattle 
Canine adenovirus 1 CAdV-1 CAU55001 Canine 
a GenBank and RefSeq accession numbers  
b The allocation of the novel AdVs to an adenovirus species is tentative  




















Figure 1. DPOL sequence-based phylogenetic analysis. Partial DPOL gene sequences from the novel 
AdVs and from published NHP AdVs and human AdVs were aligned and subjected to phylogenetic 
analysis. The tree was reconstructed using maximum likelihood with the HKY85 model of 
substitutions, as described in Materials and Methods. AdVs from wild and captive NHPs discovered in 
this study are marked with red and black dots, respectively. All other NHP AdVs were reported 
previously and originated from captive animals. The branches of all AdVs that could tentatively be 
allocated to one of the species Human adenovirus A to G or to the species Simian adenovirus A are 
colored separately. Branches left without extra coloring belong to AdVs for which allocation to an AdV 
species was not possible. Bootstrap values are depicted at the nodes of the tree; nonsignificant values 
or those close to branch tips were omitted. AdV species and host compositions are indicated on the 
right. Numbers of AdVs found in each host species are given in parentheses: numbers of published 
AdVs are given before the slash, in black, and numbers of novel AdVs from this study are given 













Figure 2. Phylogenetic analysis of the hexon gene. The hexon gene sequences of the novel AdVs and 
of published NHP AdVs and human HAdVs were aligned and subjected to phylogenetic analysis. The 
tree was reconstructed using maximum likelihood with the GTR+I+G model of substitutions, as 
described in Materials and Methods. Human, chimpanzee, bonobo, and gorilla AdVs are depicted in 
black, red, green, and blue, respectively. AdVs from wild and captive NHPs discovered in this study 
are marked with red and black dots, respectively. All other NHP AdVs were reported previously and 
originated from captive animals. The branches of all AdVs that could be allocated to one of the species 
Human adenovirus A to G or to the species Simian adenovirus A are colored separately. Branches left 
without extra coloring belong to AdVs for which tentative allocation to an AdV species was not 
possible. Bootstrap values are depicted at the nodes of the tree; nonsignificant values or those close 
to branch tips were omitted.  
 
 
 
 
 
 
  
